Pulmonary fibrosis self-management program
Part of Lungs & breathing clinical trials.
This study tests a learning and self-management program for people with pulmonary fibrosis. It helps you better understand and manage your lung condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of lung disease called fibrotic interstitial lung disease (scarring in the lungs).
- You are already part of the IIP research study at Inselspital (for patients seen there).
- You are at least 18 years old.
- You can understand and sign a consent form in German.
- You do not have sarcoidosis (a different lung condition).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how confident and positive people with fibrotic interstitial lung disease feel about managing their condition. It aims to improve support during rehabilitation.
This study tests a counseling program to help people with interstitial lung disease (a group of lung conditions that cause scarring and make breathing harder) with rehabilitation and support. It may help you cope better and stay active.
This study tests a rehabilitation program for people with pulmonary fibrosis to help improve their breathing and quality of life. It involves exercise and education, and is designed for those who are medically stable.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
Hear when a new Lung Fibrosis Interstitial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.